Partner Content Partner Content Q&A Released with West Pharmaceutical Services ahead of ... Interview released with West Pharmaceutical Services
Partner Content Partner Content MHRA to Open 10th Annual European Summit on Pre-Filled Syrin... MHRA to open PFS Europe 2018
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
